LabBase Plus celebrates pride
Search
Click to replace search prompt
Cancel
  • Click to replace search prompt Search broadly for image detection job offers Click to replace search prompt
  • Click to replace search prompt I want to find companies developing LLM Click to replace search prompt
  • Click to replace search prompt I want to work in the medical field Click to replace search prompt
  • Click to replace search prompt Find jobs in consulting that utilizes data science and AI Click to replace search prompt

Data Scientist (Machine Learning & Bioinformatics)

Craif, Inc.

  • Work Location Tokyo, Aichi
  • Company employee count 11 to 100

Job Summary

Craifについて 人々が天寿を全うする社会の実現 —— がんという人類最大の課題から、医療の未来を変える Craifは、2018年に創業した名古屋大学発のバイオAIスタートアップです。「人々が天寿を全うする社会の実現」を掲げ、がんをはじめとする病によって人生の可能性が失われることのない未来を創ろうとしています。がんは、日本では2人に1人が罹患するといわれ、4000年もの間、人類が克服できていない最も大きな課題のひとつです。一方で、がん検診の受診率は40%前後にとどまり、多くの人が早期発見の機会を逃しているのが現状です。誰もが検診の重要性を頭では理解していても、日々の忙しさや「病気は治療するもの」という意識の根強さから、行動にはなかなかつながりません。 Craifは、こうした心理的・社会的なハードルをテクノロジーで乗り越え、誰もが自然に予防・早期発見へと行動できる社会の実現に向けた根本的な課題解決に挑んでいます。 About Craif Realizing a society where people can live out their natural lifespan — changing the future of medicine, starting with cancer, humanity’s greatest challenge. Craif is a Bio-AI startup founded in 2018, originating from Nagoya University. Under the mission of “realizing a society where people can live out their natural lifespan,” the company aims to create a future where lives are no longer cut short by diseases like cancer. In Japan, it’s said that 1 in 2 people will develop cancer — a challenge humanity has been unable to overcome for over 4,000 years. Meanwhile, cancer screening rates remain around 40%, meaning many people miss the chance for early detection. Craif is using technology to overcome these psychological and social barriers, tackling the fundamental challenge of creating a society where everyone can naturally take steps toward prevention and early detection. Recruitment Background & Career Path Advanced data science expertise spanning both machine learning and biology is essential for improving the accuracy of testing systems like miSignal and developing new methods. As the business expands, there is an urgent need to strengthen the team with people who can handle everything from model development to operational automation and advancement. This position seeks someone who can lead omics data analysis and new test system development, driving the creation of clinically valuable models. In the future, this role can grow into a core R&D career involving architecture design for the entire ML pipeline and planning of new tests. Job Description Japanese is not required for this p

Company Info

Craif, Inc. is a Japanese biotechnology company focused on the research and development of next-generation diagnostic technologies, with a particular emphasis on early detection and personalized medicine for cancer and other diseases. The company provides miSignal®︎, a non-invasive cancer risk testing service available in Japan, which is based on urinary microRNA analysis. Craif utilizes a proprietary microRNA platform and sampling technology that enables the capture of low-expression RNA, facilitating the development of assays for accurate early-stage cancer prediction. Its mission is to realize a society where people can live out their natural lives by providing painless and highly accurate early cancer detection through urine testing, aiming to eliminate deaths from cancer. Founded in May 2018, Craif originated as a startup from Nagoya University.

Login to see all information about offers.

By registering with LabBase Plus you...

Picture of search page on product

You can select from our vast stock of job offers.

  • Can view all curation offers.
  • Receive notifications of new offers added to curations.
  • Possibly be scouted by corporations.
  • Search for companies with unique technologies.
  • Search for job offers in areas like inorganic chemistry material science.

Registration takes roughly 2 minutes